Expert Pharmaceutical Regulatory Consulting
The pharmaceutical and medical device sectors require strict compliance from development to post-market surveillance to ensure safety and efficacy.
Our experts support GCC registration for pharmaceutical and medical devices, covering from product classification, dossier preparation, labeling and translation, Marketing Authorization Holder registration to lifecycle management.
Why Partner With Us?
Specialized Expertise
Our team includes experienced regulatory affairs specialists with hands-on experience in drug development and regulatory submissions across multiple therapeutic areas.
Regulatory authorities we work with : include, however not limited to Emirates Drug establishment (EDE), Ministry of Health and Prevention (MoHAP), Saudi Food and Drug Authority (SFDA), European Medicines Agency (EMA), UK Medicines and Healthcare products Regulatory Authority (MHRA), United States Food and Drug administration (US FDA), Health Canada (Canadian Health Products and Food Branch) and other emerging markets.
Our Pharmaceutical Compliance Services
Medical Device & Pharma
Our Regulatory Consulting Process
01
Initial Assessment & Strategy
We start with a thorough evaluation of your product, target markets and applicable GCC regulations. Our team conducts a gap analysis and designs a tailored regulatory strategy to optimize approval timelines, reduce risks and define the most efficient path to market.
02
Regulatory Documentation-Prep
We prepare all required documentation for both pharmaceuticals and medical devices, including CTD/eCTD dossiers, CMC sections, clinical/non-clinical summaries, risk assessments, technical files, labeling, and device conformity documents in line with GCC guidelines.
03
Pre-Submission Activities
Our team coordinates pre-submission meetings with regulatory authorities, prepares briefing packages, and addresses potential queries proactively to improve approval chances and minimize review delays.
04
Submission & Review Management
We handle end-to-end submissions via GCC regulatory portals (e.g., SFDA, EDE), act as the liaison during the review process, respond to authority queries, provide clarifications and assist in negotiations to ensure smooth progression toward approval.
05
Approval & Post-Market Support
Following approval, we support ongoing compliance, including post-market surveillance, variations/updates, annual reporting, labeling changes and vigilance monitoring, ensuring your product maintains regulatory good standing in GCC markets.
Frequently Asked Questions
Q1: What pharmaceutical and medical device regulatory services does QRServes offer?
QRServes supports the full regulatory lifecycle for pharmaceutical products and medical devices in the GCC, covering product classification, CTD/eCTD dossier preparation, CMC sections, clinical and non-clinical summaries, labelling and translation, Marketing Authorization Holder (MAH) registration, and post-market lifecycle management. The team also handles pre-submission meetings, authority query responses, and ongoing compliance monitoring.
Q2: Which regulatory authorities does QRServes work with for pharmaceutical products?
QRServes works with key regulatory authorities including the Emirates Drug Establishment (EDE), UAE Ministry of Health and Prevention (MoHAP), Saudi Food and Drug Authority (SFDA) and other emerging market authorities. This broad reach makes QRServes a strategic partner for both GCC and global pharmaceutical market entry.
Q3: What is the pharmaceutical regulatory approval process with QRServes?
The process follows five stages: (1) Initial assessment and gap analysis with a tailored regulatory strategy; (2) Preparation of full regulatory documentation including dossiers, technical files, and labelling; (3) Pre-submission activities including briefing packages and proactive query management; (4) End-to-end submission management via GCC portals and authority liaison during review; and (5) Post-approval support covering surveillance, variations, annual reporting, and labelling updates.
Q4: Why is regulatory expertise critical in the pharmaceutical sector?
The pharmaceutical and medical device sectors are among the most strictly regulated industries globally, requiring compliance at every stage from development to post-market surveillance. Errors in documentation, classification, or labelling can result in rejected submissions, market entry delays, costly re-submissions, or product withdrawals. Expert regulatory support ensures submissions are complete, accurate, and aligned with the latest authority requirements, minimising risk and accelerating approval timelines.
Q5: Does QRServes support post-market compliance for pharmaceutical products?
Yes. Following product approval, QRServes provides ongoing post-market support including post-market surveillance, variation filings and lifecycle updates, annual regulatory reporting, labelling changes, and vigilance monitoring. This ensures products maintain their regulatory good standing in GCC markets and remain compliant with evolving authority requirements throughout their commercial lifecycle.
